$237.04
-0.49-0.21%
At close: Jul 16, 5:00 PM EST
$237.04
N/A
After Hours: 4:00 PM EST
Axsome Therapeutics Inc Earnings Estimates
AXSMNASDAQ
Axsome Therapeutics Earnings Estimates, EPS & Revenue | NASDAQ:AXSM
Axsome Therapeutics (AXSM) is scheduled to report Q2 earnings on August 10, 2026. Analysts estimate EPS of $-0.86 and quarterly revenue of $222.29M.
In the most recent quarter (Q1), Axsome Therapeutics reported EPS of $-1.26, missing estimates of $-0.83 by 0.52%. Revenue came in at $191.20M, exceeding the estimate of $190.28M by 0.00%.
Over the last 4 quarters, Axsome Therapeutics has averaged an EPS surprise of 0.38% and a revenue surprise of 0.04%.
Earnings Date
Aug 10
EPS Estimate
$-0.860
Quarterly Revenue Estimate
$222.29M
Annual Revenue
(as of Mar 31)
(as of Mar 31)
$708.24M
Axsome Therapeutics Earnings History
Analyze the earnings history of Axsome Therapeutics using advanced sorting and filters.
Loading calendar...
Axsome Therapeutics (AXSM) Earnings Per Share
The chart below shows Axsome Therapeutics's reported EPS compared to analyst estimates over recent quarters.
Axsome Therapeutics (AXSM) Revenue
The chart below shows Axsome Therapeutics's reported revenue compared to analyst estimates over recent quarters.
FAQ
When is Axsome Therapeutics (NASDAQ:AXSM) reporting earnings?
Axsome Therapeutics (AXSM) is scheduled to report earnings on August 10, 2026. The last reported earnings were for reported on May 4, 2026 for Q1.
What were the latest earnings per share (EPS) for Axsome Therapeutics (NASDAQ:AXSM)?
The Actual EPS was $-1.26, which missed the estimate of $-0.83.
What were Axsome Therapeutics’s (NASDAQ:AXSM) revenues?
The Actual Revenue was $191.20M, which beat the estimate of $190.28M.
